Scripps Research Identifies Erucamide as a Key Retinal Defense Against Vision Loss
Researchers at Scripps Research, UC San Diego, and the Lowy Medical Research Institute have identified erucamide, a naturally occurring lipid molecule, as a critical signaling agent that helps coordinate the retina's response to injury. Published in Nature Neuroscience on June 19, 2026, the study shows that erucamide levels decline as photoreceptors die in diseases like diabetic retinopathy and age-related macular degeneration. When researchers restored erucamide using porous silicon nanoparticles, it activated immune cells known as CD11b+ myeloid cells, which in turn stabilized the neurovascular unit. This process did not reverse degeneration but slowed the loss of tissue structure and function, suggesting a new therapeutic avenue for preserving vision in progressive retinal diseases.
